Aims-To assess the subretinal fluid (SRF) levels of ofloxacin following top
ical, oral or combined administration.
Methods-31 patients undergoing conventional retinal reattachment surgery we
re randomly assigned to three groups. Nine patients received topical ofloxa
cin, 11 patients received oral ofloxacin, and the other 11 patients receive
d combined administration. Collected SRF samples were analysed for drug lev
el by using high performance liquid chromatography.
Results-SRF drug levels after oral and combined administration were signifi
cantly higher than that after topical administration (p=0.0002 and p=0.0002
, respectively) while there was no significant difference between oral and
combined administration (p=0.0844).
Conclusions-Ocular bioavailability of ofloxacin in SRF after oral and combi
ned administration is equivalent. The addition of oral ofloxacin to topical
therapy increased drug SRF penetration sixfold.